IGI Laboratories Inc. (IG) Financials Nov 14, 2014, 4:28 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for IGI Laboratories Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 3.78M 6.09M 7.81M 8.56M 18.22M
Cost of Goods Sold (COGS) incl. D&A 3.53M 4.99M 7.7M 5.79M 12.14M
COGS excluding D&A 3.18M 4.61M 7.28M 5.33M 11.6M
Depreciation & Amortization Expense 348,000 376,000 419,000 457,000 535,000
Depreciation 248,000 276,000 319,000 357,000 375,000
Amortization of Intangibles 100,000 100,000 100,000 100,000 100,000
Gross Income 251,000 1.11M 109,000 2.78M 6.09M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.34M 4.74M 3.08M 5.91M 6.17M
Research & Development 740,000 1.51M - 2.83M 2.74M
Other SG&A 3.6M 3.23M 3.08M 3.08M 3.42M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 1,000 1,000 17,000 (13,000) 0
Non-Operating Interest Income 0 3,000 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 938,000 13,000 281,000 962,000 199,000
Gross Interest Expense 938,000 13,000 281,000 962,000 199,000
Interest Capitalized 0 0 0 0 0
Pretax Income (5.03M) (3.64M) (3.23M) (4.11M) (281,000)
Income Tax (108,000) (217,000) (226,000) (184,000) (197,000)
Income Tax - Current Domestic (108,000) (217,000) (226,000) (184,000) (197,000)
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (4.92M) (3.42M) (3.01M) (3.93M) (84,000)
Minority Interest Expense 0 0 0 0 0
Net Income (4.92M) (3.42M) (3.01M) (3.93M) (84,000)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (4.92M) (3.42M) (3.01M) (3.93M) (84,000)
Preferred Dividends 0 1.28M 0 0 1.31M
Net Income Available to Common (4.92M) (4.71M) (3.01M) (3.93M) (1.39M)
EPS (Basic) (0.46) (0.20) (0.08) (0.10) (0.03)
Basic Shares Outstanding 16.27M 23.82M 39.45M 39.79M 43.52M
EPS (Diluted) (0.46) (0.20) (0.08) (0.10) (0.03)
Diluted Shares Outstanding 16.27M 23.82M 39.45M 39.79M 43.52M
EBITDA (3.74M) (3.26M) (2.55M) (2.68M) 453,000
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for IGI Laboratories Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 3.78M 6.09M 7.81M 8.56M 18.22M
Cost of Goods Sold (COGS) incl. D&A 3.53M 4.99M 7.7M 5.79M 12.14M
COGS excluding D&A 3.18M 4.61M 7.28M 5.33M 11.6M
Depreciation & Amortization Expense 348,000 376,000 419,000 457,000 535,000
Depreciation 248,000 276,000 319,000 357,000 375,000
Amortization of Intangibles 100,000 100,000 100,000 100,000 100,000
Gross Income 251,000 1.11M 109,000 2.78M 6.09M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.34M 4.74M 3.08M 5.91M 6.17M
Research & Development 740,000 1.51M - 2.83M 2.74M
Other SG&A 3.6M 3.23M 3.08M 3.08M 3.42M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 1,000 1,000 17,000 (13,000) 0
Non-Operating Interest Income 0 3,000 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 938,000 13,000 281,000 962,000 199,000
Gross Interest Expense 938,000 13,000 281,000 962,000 199,000
Interest Capitalized 0 0 0 0 0
Pretax Income (5.03M) (3.64M) (3.23M) (4.11M) (281,000)
Income Tax (108,000) (217,000) (226,000) (184,000) (197,000)
Income Tax - Current Domestic (108,000) (217,000) (226,000) (184,000) (197,000)
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (4.92M) (3.42M) (3.01M) (3.93M) (84,000)
Minority Interest Expense 0 0 0 0 0
Net Income (4.92M) (3.42M) (3.01M) (3.93M) (84,000)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (4.92M) (3.42M) (3.01M) (3.93M) (84,000)
Preferred Dividends 0 1.28M 0 0 1.31M
Net Income Available to Common (4.92M) (4.71M) (3.01M) (3.93M) (1.39M)
EPS (Basic) (0.46) (0.20) (0.08) (0.10) (0.03)
Basic Shares Outstanding 16.27M 23.82M 39.45M 39.79M 43.52M
EPS (Diluted) (0.46) (0.20) (0.08) (0.10) (0.03)
Diluted Shares Outstanding 16.27M 23.82M 39.45M 39.79M 43.52M
EBITDA (3.74M) (3.26M) (2.55M) (2.68M) 453,000
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
